Lipids and Diabetic Retinopathy.

Item

http://www.wikidata.org/entity/Q53205337

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Lipids and Diabetic Retinopathy.

@en

Lipids and Diabetic Retinopathy.

@nl

type

Item

label

Lipids and Diabetic Retinopathy.

@en

Lipids and Diabetic Retinopathy.

@nl

prefLabel

Lipids and Diabetic Retinopathy.

@en

Lipids and Diabetic Retinopathy.

@nl

P1476

Lipids and Diabetic Retinopathy.

@en

P2093

Amar U Kishan

http://www.w3.org/2001/XMLSchema#string

Bobeck S Modjtahedi

http://www.w3.org/2001/XMLSchema#string

Namrata Bose

http://www.w3.org/2001/XMLSchema#string

Thanos D Papakostas

http://www.w3.org/2001/XMLSchema#string

P2860

Lipid peroxidation: pathophysiological and pharmacological implications in the eye

Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease?

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

PPARalpha: an emerging therapeutic target in diabetic microvascular damage.

Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group.

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

The pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathies

Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?

Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation.

P304

10-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08820538.2015.1114869

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Demetrios Vavvas

Lawrence S. Morse

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26959124

http://www.w3.org/2001/XMLSchema#string